Starting from Sunday, March 31, certain groups of patients will have the chance to buy medical marijuana and its derivatives with a prescription, without needing a special license. These groups include cancer patients undergoing chemotherapy or radiation, individuals with inflammatory bowel diseases like Crohn’s disease or ulcerative colitis, multiple sclerosis patients, those with Parkinson’s syndrome and Tourette’s syndrome, HIV patients, epilepsy sufferers, dementia patients, terminally ill individuals and people diagnosed with autism spectrum disorder.
These patients can obtain cannabinoid drugs through a prescription from a doctor in a hospital or health insurance fund. Private doctors are not authorized to write these prescriptions. The reform aims to simplify the process of accessing medical marijuana and eliminate intermediaries who charge extra fees for expediting the license application process. Prescriptions will be electronic and can be written up to one year in advance by specialist doctors.
The change will make it easier for those who still require a license to access medical marijuana, removing the requirement for patients to exhaust all other treatment options before using it. With these changes, the goal is to streamline the process of accessing medical marijuana for those in need and make it more efficient and beneficial for them.
